The effects of pemafibrate in Japanese patients with type 2 diabetes receiving HMG-CoA reductase inhibitors - Kusunoki, M; Sakazaki, T; Tsutsumi, K (Endocrine, Metabolic & Immune Disorder-Drug Target (EMIDDT), 2021)